FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294292783> ?p ?o ?g. }

• W4294292783 endingPage "PO019" @default.
• W4294292783 startingPage "PO019" @default.
• W4294292783 abstract "Abstract The receptor tyrosine kinase Axl, binding to its ligand Gas6, fosters oncogenic effects during the progression of hepatocellular carcinoma (HCC) which is accompanied by increased mortality of patients. The specific role of Gas6/Axl signaling in neoplastic hepatocytes and its pathophysiological consequences are poorly understood at the current stage of research. We aimed at identifying and functionally analyzing targets of Gas6/Axl signaling in HCC by exploiting well-characterized human HCC tumor models. HCC cells transformed by epithelial to mesenchymal transition (EMT) and expressing high levels of Axl or harboring CRISPR/Cas9-mediated Axl deficiency, the latter in absence or presence of Axl reconstitution, were subjected to Gas6 stimulation and subsequent RNA-seq analysis. Bioinformatics and VENN relations were applied to identify novel targets of the Gas6/Axl axis. Expression of Gas6/Axl targets was assessed in publicly available HCC patient datasets and in HCC tissue microarrays. In vitro analysis was performed including gain and loss of functions studies to unravel target genes contribution to EMT and HCC progression. RNA-seq analyses revealed PRAME (preferentially expressed antigen in melanoma) and C15orf48 among others as novel targets of Gas6/Axl. Notably, these target genes showed elevated expression levels in Axl-stratified HCC patients and significant impact on patient survival. Pharmacological or genetic interference with Axl signaling resulted in strongly reduced expression of PRAME and C15orf48, suggesting bona fide targets of Gas6/Axl signaling. PRAME expression positively regulated 2D cell migration and invasion of 3D hepatospheres while proliferation and survival of HCC cells remained unaffected by altered PRAME levels. In accordance, PRAME expression strongly associated with a mesenchymal-like phenotype in human HCC. Intriguingly, HCC patients expressing PRAME correlated with Axl expression and vascular invasion in a large proportion of HCC patients. Our study demonstrates that PRAME is a novel target of Gas6/Axl signaling in HCC linked to EMT. Translation of in vitro findings into the HCC patient situation provides first insights that PRAME plays a crucial role in HCC progression. Citation Format: Viola Hedrich, Doris Chen, Heidemarie Huber, Wolfgang Mikulits. Gas6/Axl signaling induces PRAME expression in hepatocellular carcinoma [abstract]. In: Proceedings of the AACR Special Conference: Advances in the Pathogenesis and Molecular Therapies of Liver Cancer; 2022 May 5-8; Boston, MA. Philadelphia (PA): AACR; Clin Cancer Res 2022;28(17_Suppl):Abstract nr PO019." @default.
• W4294292783 created "2022-09-02" @default.
• W4294292783 creator A5059941839 @default.
• W4294292783 creator A5066055526 @default.
• W4294292783 creator A5072982476 @default.
• W4294292783 creator A5085988278 @default.
• W4294292783 date "2022-09-01" @default.
• W4294292783 modified "2023-09-26" @default.
• W4294292783 title "Abstract PO019: Gas6/Axl signaling induces PRAME expression in hepatocellular carcinoma" @default.
• W4294292783 doi "https://doi.org/10.1158/1557-3265.liverca22-po019" @default.
• W4294292783 hasPublicationYear "2022" @default.
• W4294292783 type Work @default.
• W4294292783 citedByCount "0" @default.
• W4294292783 crossrefType "journal-article" @default.
• W4294292783 hasAuthorship W4294292783A5059941839 @default.
• W4294292783 hasAuthorship W4294292783A5066055526 @default.
• W4294292783 hasAuthorship W4294292783A5072982476 @default.
• W4294292783 hasAuthorship W4294292783A5085988278 @default.
• W4294292783 hasConcept C101544691 @default.
• W4294292783 hasConcept C121608353 @default.
• W4294292783 hasConcept C157333092 @default.
• W4294292783 hasConcept C172811965 @default.
• W4294292783 hasConcept C2778019345 @default.
• W4294292783 hasConcept C2779256057 @default.
• W4294292783 hasConcept C2781185341 @default.
• W4294292783 hasConcept C502942594 @default.
• W4294292783 hasConcept C5364575 @default.
• W4294292783 hasConcept C54355233 @default.
• W4294292783 hasConcept C62478195 @default.
• W4294292783 hasConcept C86803240 @default.
• W4294292783 hasConcept C95444343 @default.
• W4294292783 hasConceptScore W4294292783C101544691 @default.
• W4294292783 hasConceptScore W4294292783C121608353 @default.
• W4294292783 hasConceptScore W4294292783C157333092 @default.
• W4294292783 hasConceptScore W4294292783C172811965 @default.
• W4294292783 hasConceptScore W4294292783C2778019345 @default.
• W4294292783 hasConceptScore W4294292783C2779256057 @default.
• W4294292783 hasConceptScore W4294292783C2781185341 @default.
• W4294292783 hasConceptScore W4294292783C502942594 @default.
• W4294292783 hasConceptScore W4294292783C5364575 @default.
• W4294292783 hasConceptScore W4294292783C54355233 @default.
• W4294292783 hasConceptScore W4294292783C62478195 @default.
• W4294292783 hasConceptScore W4294292783C86803240 @default.
• W4294292783 hasConceptScore W4294292783C95444343 @default.
• W4294292783 hasIssue "17_Supplement" @default.
• W4294292783 hasLocation W42942927831 @default.
• W4294292783 hasOpenAccess W4294292783 @default.
• W4294292783 hasPrimaryLocation W42942927831 @default.
• W4294292783 hasRelatedWork W1969485126 @default.
• W4294292783 hasRelatedWork W2128841304 @default.
• W4294292783 hasRelatedWork W2132169351 @default.
• W4294292783 hasRelatedWork W2568917916 @default.
• W4294292783 hasRelatedWork W2738852905 @default.
• W4294292783 hasRelatedWork W2885652183 @default.
• W4294292783 hasRelatedWork W2912251126 @default.
• W4294292783 hasRelatedWork W3211719649 @default.
• W4294292783 hasRelatedWork W4294292783 @default.
• W4294292783 hasRelatedWork W4362541995 @default.
• W4294292783 hasVolume "28" @default.
• W4294292783 isParatext "false" @default.
• W4294292783 isRetracted "false" @default.
• W4294292783 workType "article" @default.